Update on Potential Unification 19 March 2021 Throughout its history going back to 1957, Diabetes Australia has been a federated organisation and its members have been State and Territory diabetes organisations, later joined by Health Professional Organisations and Research Organisations. Recently, the Member Organisations of Diabetes Australia voted unanimously to change the Constitution of Diabetes Australia to enable Member Organisations to merge and unify with Diabetes Australia. Importantly, the Member Organisations can choose if, and when, they will merge and unify with Diabetes Australia – and this will be through the individual members of those organisations voting on whether to unify or not. A Member Organisation may choose not to merge and may remain a Member Organisation. The objective is to create a larger, national community for diabetes with a stronger voice to advocate for affordable diabetes care, new technologies, more research, and enhanced diabetes services from all levels of government. A more unified national organisation will also have a greater opportunity to raise much needed funds to support more diabetes research, diabetes services and advocacy. The National Health Professional organisations (the Australian Diabetes Society and the Australian Diabetes Educators Association) may also merge but retain their names and activities to continue the power of combined consumer and health professional advocacy and activity. The benefits of this includes alignment on policy and advocacy issues; consistency and collaboration across all diabetes organisations; and a powerful voice to enhance diabetes research, management and education services and make a real difference to people living with diabetes and their families. The potential unification will be a staged process over the coming months and years. We will provide regular updates as we work towards a more unified, successful future so that we may best support people living with diabetes, their families/supporters and diabetes health professionals.
News 27 May 2026 Urgent product correction for MiniMed Android App Medtronic and the Therapeutic Goods Administration have issued an Urgent Product Correction for a MiniMed Mobile App Android software version... Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
News 27 May 2026 Important recall: Selected Omnipod® 5 and Omnipod DASH® Pods Insulet has issued a critical recall affecting specific lots of Omnipod 5 and Omnipod DASH Pods after identifying a manufacturing... Continue Reading